Marker Therapeutics, Inc. (MRKR) › Total LiabilitiesMarker Therapeutics, Inc. (MRKR) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2016: $1.74M2017: $1.52M2018: $2.80M2019: $2.27M2020: $18.27M2021: $24.15M2022: $14.82M2023: $3.07M2024: $3.46M2025: $2.27M$2.27M2016Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$2.27M-34.4%2024$3.46M+12.7%2023$3.07M-79.3%2022$14.82M-38.6%2021$24.15M+32.2%2020$18.27M+703.8%2019$2.27M-18.9%2018$2.80M+84.2%2017$1.52M-12.3%2016$1.74M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share